Ulrich Jäger
- Hematology top 0.2%
- Molecular Biology top 5%
- Oncology top 2%
- Genetics top 0.5%
- Immunology top 2%
- Co-authors
- Klaus LechnerPeter ValentAndreas ChottIlse SchwarzingerKlaus GeißlerWolfgang R. SperrJohannes DrachPaul Knöbl
- Topics
- Acute Myeloid Leukemia Research (38 papers)Lymphoma Diagnosis and Treatment (38 papers)Chronic Lymphocytic Leukemia Research (37 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Ulrich Jäger
169 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Hematology 2.4k
- Molecular Biology 1.8k
- Oncology 1.7k
- Genetics 1.2k
- Immunology 1.2k
Countries citing papers authored by Ulrich Jäger
This map shows the geographic impact of Ulrich Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Jäger more than expected).
Fields of papers citing papers by Ulrich Jäger
This network shows the impact of papers produced by Ulrich Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Jäger. The network helps show where Ulrich Jäger may publish in the future.
Co-authorship network of co-authors of Ulrich Jäger
This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Jäger. A scholar is included among the top collaborators of Ulrich Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Jäger. Ulrich Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 11 | |
| 4 | 8 | |
| 5 | 9 | |
| 6 | 100 | |
| 7 | 19 | |
| 8 | 13 | |
| 9 | 6 | |
| 10 | 46 | |
| 11 | 60 | |
| 12 | 27 | |
| 13 | 66 | |
| 14 | 249 | |
| 15 | 93 | |
| 16 | 51 | |
| 17 | Monotherapy with the anti-CD20 antibody rituximab (ritux) in patients with post-transplant lympho-proliferative disease (PTLD). Results of a multicentre phase II study. | 2 |
| 18 | 0 | |
| 19 | 2 | |
| 20 | 13 |
About Ulrich Jäger
Ulrich Jäger is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 172 papers that have together received 5.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (38 papers) and Chronic Lymphocytic Leukemia Research (37 papers). The work is most often cited by research in Hematology (2.4k citations), Genetics (1.2k citations) and Oncology (1.7k citations). Ulrich Jäger has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Klaus Lechner, Peter Valent, Andreas Chott, Ilse Schwarzinger, Klaus Geißler, Wolfgang R. Sperr, Johannes Drach, Paul Knöbl, Berthold Streubel and Heinz Gisslinger. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.